Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation

This publication has 14 references indexed in Scilit:

• Transplant dose of CD34⁺ and CD3⁺ cells predicts outcome in patients with haematological malignancies undergoing T cell‐depleted peripheral blood stem cell transplants with delayed donor lymphocyte add‐back
  British Journal of Haematology, 2001
• Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis
  Journal of Clinical Oncology, 2001
• CD34+ cell dose predicts relapse and survival after T‐cell‐depleted HLA‐identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies
  British Journal of Haematology, 2000
• The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation
  British Journal of Haematology, 2000
• Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia
  Bone Marrow Transplantation, 1999
• Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies
  Blood, 1991
• Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease
  Blood, 1986
• Graft rejection following HLA matched T‐lymphocyte depleted bone marrow transplantation
  British Journal of Haematology, 1986
• Bone-Marrow Transplantation
  New England Journal of Medicine, 1975
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958